Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Weight gain, metabolic disturbances, and physical health care in a Brazilian sample of outpatients with schizophrenia.

Gordon PC, Xavier JC, Louzã MR.

Neuropsychiatr Dis Treat. 2013;9:133-8. doi: 10.2147/NDT.S37019. Epub 2013 Jan 17.

2.

Metabolic risk during antipsychotic treatment.

Newcomer JW.

Clin Ther. 2004 Dec;26(12):1936-46. Review.

PMID:
15823759
3.

[Psychotropic drugs induced weight gain: a review of the literature concerning epidemiological data, mechanisms and management].

Ruetsch O, Viala A, Bardou H, Martin P, Vacheron MN.

Encephale. 2005 Jul-Aug;31(4 Pt 1):507-16. Review. French.

PMID:
16389718
4.
5.

Long-term health considerations in schizophrenia: metabolic effects and the role of abdominal adiposity.

Van Gaal LF.

Eur Neuropsychopharmacol. 2006 Sep;16 Suppl 3:S142-8. Epub 2006 Jul 24. Review.

PMID:
16863690
6.

[Schizophrenia, diabetes mellitus and antipsychotics].

Gury C.

Encephale. 2004 Jul-Aug;30(4):382-91. Review. French.

PMID:
15538314
8.

Obesity and related metabolic abnormalities during antipsychotic drug administration: mechanisms, management and research perspectives.

Baptista T, Kin NM, Beaulieu S, de Baptista EA.

Pharmacopsychiatry. 2002 Nov;35(6):205-19. Review.

PMID:
12518268
9.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

10.

Metabolic syndrome and mental illness.

Newcomer JW.

Am J Manag Care. 2007 Nov;13(7 Suppl):S170-7. Review. Erratum in: Am J Manag Care. 2008 Feb;14(2):76.

11.

Reducing cardiovascular risk factors in non-selected outpatients with schizophrenia.

Hansen MV, Hjorth P, Kristiansen CB, Vandborg K, Gustafsson LN, Munk-Jørgensen P.

Int J Soc Psychiatry. 2016 Jun;62(4):400-7. doi: 10.1177/0020764016629494. Review.

PMID:
27261497

Supplemental Content

Support Center